— Know what they know.
Not Investment Advice

CMRX NASDAQ

Chimerix, Inc.
1W: +0.2% 1M: +0.8% 3M: +140.6% 1Y: +844.7% 3Y: +82.1% 5Y: +454.6%
$8.54
Last traded 2025-04-21 — delisted
NASDAQ · Healthcare · Biotechnology · $801.1M mcap · 80M float · 5.30% daily turnover · Short 39% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$212K -34.6% ▼
5Y CAGR: -55.8%
Gross Profit
$212K -34.6% ▼
Operating Income
-$97M -3.8% ▼
Net Income
-$88M -7.7% ▼
EPS (Diluted)
$-0.99 -6.5% ▼
EBITDA
-$96M -3.8% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$5M$2M$34M$324K$212K
YoY Growth-57.1%-63.2%+1609.1%-99.0%-34.6%
Cost of Revenue$36M$468K$447K$0$0
Gross Profit-$31M$2M$33M$324K$212K
Gross Margin-574.5%76.4%98.7%100.0%100.0%
R&D Expenses$36M$74M$72M$69M$75M
SG&A Expenses$14M$19M$22M$25M$22M
Operating Expenses$50M$92M$94M$93M$97M
Operating Income-$45M-$173M-$60M-$93M-$97M
Operating Margin-828.7%-8762.0%-178.5%-28723.8%-45550.5%
Interest Expense$0$0$0$0$0
Income Before Tax-$44M-$173M$172M-$82M-$88M
Tax Expense$0$0$36K$0$0
Net Income-$42M-$256M$172M-$82M-$88M
Net Margin-784.2%-12925.5%509.0%-25338.0%-41692.0%
EPS (Diluted)$-0.68$-3.01$1.94$-0.93$-0.99
EBITDA-$44M-$90M-$60M-$93M-$96M
Shares Outstanding62M85M89M89M90M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms